DLST expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.621200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.115000E-01
Normal-vs-Stage2
7.820600E-01
Normal-vs-Stage3
3.165000E-01
Normal-vs-Stage4
3.885400E-01
Stage1-vs-Stage2
2.515800E-01
Stage1-vs-Stage3
4.916200E-01
Stage1-vs-Stage4
1.175840E-01
Stage2-vs-Stage3
9.865900E-02
Stage2-vs-Stage4
4.648600E-01
Stage3-vs-Stage4
1.032360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.198800E-01
Normal-vs-AfricanAmerican
8.216000E-01
Normal-vs-Asian
4.480000E-01
Caucasian-vs-AfricanAmerican
4.771600E-01
Caucasian-vs-Asian
6.066200E-02
AfricanAmerican-vs-Asian
5.804800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.205800E-01
Normal-vs-Female
9.239200E-01
Male-vs-Female
6.498400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.870800E-01
Normal-vs-Age(41-60Yrs)
5.187600E-01
Normal-vs-Age(61-80Yrs)
9.956800E-01
Normal-vs-Age(81-100Yrs)
8.675400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.233200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.014400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.295000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.503800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.801800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.988800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.467600E-01
Normal-vs-Daily Drinker
8.640200E-01
Normal-vs-Weekly Drinker
8.824000E-01
Normal-vs-Occasional Drinker
6.408800E-01
Normal-vs-Social Drinker
7.713400E-01
Non Drinker-vs-Daily Drinker
3.066200E-01
Non Drinker-vs-Weekly Drinker
5.075200E-01
Non Drinker-vs-Occasional Drinker
1.543830E-01
Non Drinker-vs-Social Drinker
2.687400E-01
Daily Drinker-vs-Weekly Drinker
9.311200E-01
Daily Drinker-vs-Occasional Drinker
8.022200E-01
Daily Drinker-vs-Social Drinker
9.600400E-01
Weekly Drinker-vs-Occasional Drinker
9.629200E-01
Weekly Drinker-vs-Social Drinker
9.535600E-01
Occasional Drinker-vs-Social Drinker
8.193000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.785600E-01
Normal-vs-Grade 2
6.652600E-01
Normal-vs-Grade 3
6.089800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.679600E-02
Grade 1-vs-Grade 3
3.959500E-03
Grade 1-vs-Grade 4
7.785600E-01
Grade 2-vs-Grade 3
1.712010E-01
Grade 2-vs-Grade 4
6.652600E-01
Grade 3-vs-Grade 4
6.089800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.901200E-01
Normal-vs-NonDiabetic
8.904800E-01
Diabetic-vs-NonDiabetic
6.361200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.276800E-01
Normal-vs-NoPancreatitis
9.056000E-01
Pancreatitis-vs-NoPancreatitis
6.979600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.823800E-01
Normal-vs-N1
7.883600E-01
N0-vs-N1
3.679200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.874200E-01
Normal-vs-TP53-NonMutant
7.193400E-01
TP53-Mutant-vs-TP53-NonMutant
4.14210000000415E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
